Medical students’ knowledge of medication related osteonecrosis of the jaw

Franchi, Stefano; Brucoli, Matteo; Boffano, Paolo; Dosio, Camilla; Benech, Arnaldo

doi:10.1016/j.jormas.2019.10.005

Cited by 17 publications

(18 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[ 15 ], found that 56.5% of dentists were familiar with BRONJ, and 31.4% documented BP use in their patients' medical history. A more recent similar research among medical students by S. Franchi et al 2019 was showing results in agreement with our results more specifically the deficiency in knowledge about medications that predispose patients to the jaw necrosis [ 17 ].…”

Section: Discussionsupporting

confidence: 93%

Dentists' knowledge about medication-related osteonecrosis of the jaw and its management

Al-Eid

Alduwayan

Khuthaylah

et al. 2020

Heliyon

View full text Add to dashboard Cite

Objectives To assess the knowledge of dentists regarding medication-related osteonecrosis of the jaw (MRONJ). Methods In this cross-sectional study, 74 dentists from governmental hospitals in Riyadh (Dental University Hospital in King Saud University, Military Hospital, National Guard Hospital), Jeddah (King Abdulaziz University Hospital, Ministry of Health Hospital), and the Eastern region of Saudi Arabia (Ministry of Health Hospitals in Dammam and Al-Ahsa) completed a two-part questionnaire. The first part gathered demographic data, such as sex and specialty. The second part included questions about bisphosphonate drugs and their indications; the identification of patients at risk of MRONJ; other medications associated with jaw necrosis; as well as the definition of MRONJ and its clinical features, risk factors, and preventive methods. Results Of the participating dentists, 60.8% knew about MRONJ, but only 35.1% were able to define it correctly. Most (79.7%) had never encountered MRONJ patients. Only 18.9% knew of the relationship between the risk of MRONJ in osteoporotic patients and long-term (>4 years) use of oral bisphosphonates or intravenous zoledronate, while 68.9% were unaware, and others answered incorrectly. Most participants did not know of MRONJ-predisposing medications, and 59.5% cited radiotherapy as the cause. Most participants identified dentoalveolar surgery as a major local factor, and the mandible as a common anatomic location. Conclusion Dentists at the surveyed institutions had poor knowledge of MRONJ, although their knowledge of preventive measures was good. There is an urgent need for the optimization of educational programs pertaining to MRONJ, and its related dental management considerations. Clinical significance Dentists in the surveyed institutions in Kingdom of Saudi Arabia have poor knowledge of MRONJ management; thus, greater effort should be taken to educate undergraduate and postgraduate students regarding this pathology.

show abstract

Section: Discussionsupporting

confidence: 93%

Dentists' knowledge about medication-related osteonecrosis of the jaw and its management

Al-Eid

Alduwayan

Khuthaylah

et al. 2020

Heliyon

View full text Add to dashboard Cite

show abstract

“…To the best of our knowledge, this is the first study assessing MRONJ knowledge among dental practitioners and dentistry students from Poland. Comparing the obtained results with those from similar studies carried out in other countries, responses of participants in our study are on a satisfactory level and stand out positively compared to other surveys [13,15,19,20].…”

Section: Discussionsupporting

confidence: 82%

“…The results show that although 94.6% of respondents know about the existence of such a disease, only 33.7% know that BP, denosumab and angiogenesis inhibitors are drugs that increase the risk of MRONJ. In the research of Franchi, who assessed the knowledge of medical students in Italy in his study, out of 72 respondents, only 12 (16.7%) possessed knowledge about the type of drugs that increased the risk of MRONJ [20]. Without this crucial knowledge about therapeutics, the risk of treatment complication is elevated.…”

Section: Discussionmentioning

confidence: 99%

“…Researchers in Italy obtained much more promising results on this subject among students of the last two years of medicine. Almost all students (71 out of 72 respondents) replied that a dental examination was needed before starting bisphosphonate therapy [20]. Better education on this subject during medical studies may result in greater awareness of the prevention, risk factors and management of MRONJ among young physicians.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Awareness of Medication-Related Osteonecrosis of the Jaws amongst Dental Professionals in Poland

et al. 2021

View full text Add to dashboard Cite

Background: Medication-Related Osteonecrosis of the Jaws (MRONJ) is a serious complication of antiresorptive therapy. The aim of the study was to assess the level of knowledge and awareness regarding MRONJ among Polish dentists and students of dentistry. Methods: The online self-administered questionnaire was sent out electronically among dentists in Poland and dentistry students of the Medical University of Gdansk. The results obtained were statistically analyzed. The results were considered statistically significant if the condition p ≤ 0.05 was met. Results: A total of 203 respondents participated in this survey. A total of 94.6% of them declared knowledge of the term MRONJ. However, the length of bisphosphonates persistence in the body was known to 51.5% of participants, while the knowledge of oral and maxillofacial surgeons concerning this topic was significantly higher (87.0%). Conclusion: Dental and maxillofacial surgeons presented the highest level of knowledge about MRONJ. The remaining groups did not differ in their knowledge. It must be noted that the knowledge of the students was similar to that of dentists. A better level of knowledge by dentists could contribute to a decline of the occurrence of the disease in future. Theoretical and practical initiatives should be promoted to improve the knowledge about MRONJ.

show abstract

“…Los incrementos en las prescripciones de medicamentos para prevenir la osteoporosis ha llevado a la necesidad de que los estudiantes y profesionales de la salud conozcan sobre los diferentes medicamentos asociados al BRONJ y sobre los esquemas de manejo preventivo y de tratamiento 27,28,29 , al igual que en pacientes que puedan estar a riesgo 30 .…”

Section: Introductionunclassified

Osteonecrosis of the jaw associated to biphosponates in Cali-Colombia

Arcila¹,

Llano²

2020

Rev Estomatol

View full text Add to dashboard Cite

Background: After more than 15 years of the first report of osteonecrosis associated with bisphosphonate (BP), still cases related to BP and other medications continue to be reported and there is an alert about the increase in the number of prescriptions. The need for both patients and students and health professionals to be familiar with medications, pathology, prevention and treatment measures has been highlighted. Aim: To characterize patients with osteonecrosis in the maxilla associated to bisphosphonate (BRONJ), from Cali, Colombia. Materials and Methods: A structured survey was conducted of 32 maxillofacial surgeons from the city of Cali, Colombia, where different topics related to affected patients and the development of the pathology such as age and gender of patients, type of medication, time of study were asked. administration, exposed bone, etc. Results: Thirty-two maxillofacial surgeons answered the survey with a total of 8 cases, it was found that 6 corresponded to women and 2 to men and the age was over 44 years; 4 of the treatments were oral prescription and 4 intravenous; the majority of cases were presented in the jaw (88%) and 6 cases (75%) presented bone exposure. Conclusions: Osteonecrosis associated with bisphosphonates is a situation that still occurs and could increase its incidence due to the increase in the number of prescriptions for osteoporosis medications, it is necessary that the patient community and health staff know More about this situation.

show abstract

Medical students’ knowledge of medication related osteonecrosis of the jaw

Cited by 17 publications

References 17 publications

Dentists' knowledge about medication-related osteonecrosis of the jaw and its management

Dentists' knowledge about medication-related osteonecrosis of the jaw and its management

Awareness of Medication-Related Osteonecrosis of the Jaws amongst Dental Professionals in Poland

Osteonecrosis of the jaw associated to biphosponates in Cali-Colombia

Contact Info

Product

Resources

About